Published works from the Kiss RNA Lab
(Kiss RNA Lab members underlined, Dr. Kiss in bold; presented in chronological order -with most recent first-)
- Kiss DL, Vasudevan D, Ho CK and Caliskan N (2022) Editorial: mRNA Translational Control as a Mechanism of Post-transcriptional Gene Regulation. Front. Mol. Biosci. 9:947516. doi: 10.3389/fmolb.2022.947516
- Yu Y, Alvarado R, Petty LE, Bohlender RJ, Shaw DM, Below JE, Bejar N, Ruiz OE, Tandon B, Eisenhoffer GT, Kiss D.L., Huff CD, Letra A, Hecht JT. Polygenic risk impacts PDGFRA mutation penetrance in nonsyndromic cleft lip and palate. Hum Mol Genet. 2022 Feb 11 DOI:10.1093/hmg/ddac037
- Bejar, N., Tat, T.T., and Kiss, D.L., RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases. Current Atherosclerosis Reports, 2022. https://doi.org/10.1007/s11883-022-01007-9
- Tat TT, Kiss D.L. From m6A to Cap-Adjacent m6Am and their Effects on mRNAs. In: Jurga S, Barciszewski J, editors. Epitranscriptomics [Internet] 12 ed. Springer Nature Switzerland AG 2021: Springer Nature; Chapter 12; p.325-352. 632p. https://doi.org/10.1007/978-3-030-71612-7.
- – A preprint of the above peer-reviewed book chapter prior to peer review and before copy editing. Please note, this preprint includes a significantly expanded reference list which includes ~100 additional references that were deleted during revision.-
- Berger MR, Alvarado R, Kiss, D.L., mRNA 5′ ends targeted by cytoplasmic recapping cluster at CAGE tags and select transcripts are alternatively spliced. FEBS Lett. 2019 Apr;593(7):670-679. PMID: 30810230 *Editor’s Choice selection– Follow this Youtube link for a ~30 minute live-streamed presentation of this work.
Coming soon (Accepted and in Press):
- Damase, T., Zhang, M., Sukhovershin, R. S., Kiss, D.L., and Cooke, J.P., Hospital-Based RNA Therapeutics, Messenger RNA Therapeutics Book chapter, Springer/Nature.
– A preprint of the above peer-reviewed book chapter before copy editing is available via this link.
Submitted works from the Kiss RNA Lab:
No manuscripts are currently submitted, but 2 research articles and 1 review are ‘in the works’ right now.
Published works from Dr. Kiss’s postdoc:
- Kiss, D.L., Baez, W.D., Bundschuh, R.A., Huebner, K, and Schoenberg D.R. (2018) Loss of Fragile Histidine Triad (Fhit) protein expression alters the translation of cancer-associated mRNAs. BMC Res Notes. 2018/Mar 14;11(1):178. PMID: 29540221
- Kiss, D.L., Baez, W.D., Bundschuh, R.A., Huebner, K, and Schoenberg D.R. (2017) Impact of Fhit on the translation of cancer-associated mRNAs. Molecular Cancer. Dec 28;16(1):179. PMID: 29282095
- Kiss, D.L., Waters, C.E., Ouda, I.M., Saldivar, J.C., Karras, J.R., Amin, Z.A., Mahrous, S., Druck, T., Bundschuh, R.A., Huebner, K and D.R. Schoenberg. (2017) Identification of Fhit as a Post-transcriptional Effector of Thymidine Kinase 1 Expression. BBA Gene Regulatory Mechanisms. Jan 14;1860(3):374-38. PMID: 28093273
- Kiss, D.L., Oman, K., Dougherty, J., Mukherjee, C.M., Bundschuh, R., and D.R. Schoenberg, (2016) Cap homeostasis is independent of poly(A) tail length. Nucl Acids Res. Jan 8;44(1):304-14. ; PMID: 26673707
- Kiss, D.L., Oman, K., Bundschuh, R., and D.R. Schoenberg, (2015) Uncapped 5’ ends of mRNAs targeted by cytoplasmic capping map to the vicinity of downstream CAGE tags. FEBS Lett. Jan 30;589(3):279-84. PMID: 25541487